HQY HealthEquity, Inc.

NASDAQ
$94.75

HealthEquity, Inc. (HQY) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Moderately bearish Selling ran elevated versus HQY's own trailing one-year pace, with 100% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 1 buyer in the last 90 days 2 sellers in the last 90 days
Insiders buying
1
2 transactions
Insiders selling
5
8 transactions
Purchases
$11.9K
131 shares
Sales
$2.5M
25,645 shares
Net activity
-$2.4M
purchases less sales

How much of that selling was preplanned? 100% planned / 0% discretionary

10b5-1 plan sales $2.4M 7 transactions · 25,537 shares
Discretionary sales $11.4K 1 transaction · 108 shares

Largest single sale: $675.0K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: October 15, 2026 , by Rajasekar Sunil .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Rajasekar Sunil EVP Chief Prod & Strat Officer Buy 108 $90.33 $9.8K 53,405
DILLON ADRIAN T 2 fills Director Sell 10b5-1 7,632 $104.61 $798.4K 63,727 −10.7% of holding
Rajasekar Sunil EVP Chief Prod & Strat Officer Sell 108 $105.60 $11.4K 53,297 −0.2% of holding
Fiore Michael Henry EVP, CHIEF COMMERCIAL OFFICER Sell 10b5-1 2,354 $95.00 $223.6K 52,244 −4.3% of holding
Rajasekar Sunil EVP Chief Prod & Strat Officer Buy 23 $95.06 $2.2K 53,405
Fiore Michael Henry EVP, CHIEF COMMERCIAL OFFICER Sell 10b5-1 2,470 $95.00 $234.7K 56,643 −4.2% of holding
Fiore Michael Henry EVP, CHIEF COMMERCIAL OFFICER Sell 10b5-1 3,142 $95.00 $298.5K 59,113 −5% of holding
Ladd Delano EVP, General Counsel Sell 10b5-1 7,500 $90.00 $675.0K 91,141 −7.6% of holding
Wellborn Gayle Furgurson Director Sell 10b5-1 2,439 $90.00 $219.5K 19,733 −11% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.